These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 9266732)

  • 1. Dopamine D1 and D2 receptor gene expression in the striatum in Huntington's disease.
    Augood SJ; Faull RL; Emson PC
    Ann Neurol; 1997 Aug; 42(2):215-21. PubMed ID: 9266732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Striatal D1 and D2 dopamine receptor loss in asymptomatic mutation carriers of Huntington's disease.
    Weeks RA; Piccini P; Harding AE; Brooks DJ
    Ann Neurol; 1996 Jul; 40(1):49-54. PubMed ID: 8687191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypical characterization of the neurons expressing the D1 and D2 dopamine receptors in the monkey striatum.
    Aubert I; Ghorayeb I; Normand E; Bloch B
    J Comp Neurol; 2000 Feb; 418(1):22-32. PubMed ID: 10701753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organization of dopamine D1 and D2 receptors in human striatum: receptor autoradiographic studies in Huntington's disease and schizophrenia.
    Joyce JN; Lexow N; Bird E; Winokur A
    Synapse; 1988; 2(5):546-57. PubMed ID: 2973147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D1 and D2 dopamine receptor gene expression in the rat striatum: sensitive cRNA probes demonstrate prominent segregation of D1 and D2 mRNAs in distinct neuronal populations of the dorsal and ventral striatum.
    Le Moine C; Bloch B
    J Comp Neurol; 1995 May; 355(3):418-26. PubMed ID: 7636023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
    Huot P; Lévesque M; Parent A
    Brain; 2007 Jan; 130(Pt 1):222-32. PubMed ID: 17142832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes of D1 and D2 dopamine receptor mRNA in the brains of monkeys lesioned with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: correction with chronic administration of L-3,4-dihydroxyphenylalanine.
    Morissette M; Goulet M; Calon F; Falardeau P; Blanchet PJ; Bédard PJ; Di Paolo T
    Mol Pharmacol; 1996 Nov; 50(5):1073-9. PubMed ID: 8913337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential electrophysiological properties of dopamine D1 and D2 receptor-containing striatal medium-sized spiny neurons.
    Cepeda C; André VM; Yamazaki I; Wu N; Kleiman-Weiner M; Levine MS
    Eur J Neurosci; 2008 Feb; 27(3):671-82. PubMed ID: 18279319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in dopamine and benzodiazepine receptor binding precede overt neuronal pathology in mice modelling early Huntington disease pathogenesis.
    Kennedy L; Shelbourne PF; Dewar D
    Brain Res; 2005 Mar; 1039(1-2):14-21. PubMed ID: 15781041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Striatal neurochemical changes in transgenic models of Huntington's disease.
    Ariano MA; Aronin N; Difiglia M; Tagle DA; Sibley DR; Leavitt BR; Hayden MR; Levine MS
    J Neurosci Res; 2002 Jun; 68(6):716-29. PubMed ID: 12111832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Striatal interneurons in Huntington's disease: selective increase in the density of calretinin-immunoreactive medium-sized neurons.
    Cicchetti F; Parent A
    Mov Disord; 1996 Nov; 11(6):619-26. PubMed ID: 8914086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The fate of the large striatal interneurons expressing calretinin in Huntington's disease.
    Massouh M; Wallman MJ; Pourcher E; Parent A
    Neurosci Res; 2008 Dec; 62(4):216-24. PubMed ID: 18801393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preproenkephalin messenger RNA-containing neurons in striatum of patients with symptomatic and presymptomatic Huntington's disease: an in situ hybridization study.
    Albin RL; Qin Y; Young AB; Penney JB; Chesselet MF
    Ann Neurol; 1991 Oct; 30(4):542-9. PubMed ID: 1838677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GABA-ergic interneurons of the striatum express the Shaw-like potassium channel Kv3.1.
    Lenz S; Perney TM; Qin Y; Robbins E; Chesselet MF
    Synapse; 1994 Sep; 18(1):55-66. PubMed ID: 7825124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localization of dopamine receptors and associated mRNA in transplants of human fetal striatal tissue in rodents with experimental Huntington's disease.
    Pundt LL; Narang N; Kondoh T; Low WC
    Neurosci Res; 1997 Apr; 27(4):305-15. PubMed ID: 9152043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localization of dopaminergic markers in the human subthalamic nucleus.
    Augood SJ; Hollingsworth ZR; Standaert DG; Emson PC; Penney JB
    J Comp Neurol; 2000 May; 421(2):247-55. PubMed ID: 10813785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of D1 but not D2 dopamine receptors in striatal neurons producing neurokinin B in rats.
    Sonomura T; Nakamura K; Furuta T; Hioki H; Nishi A; Yamanaka A; Uemura M; Kaneko T
    Eur J Neurosci; 2007 Dec; 26(11):3093-103. PubMed ID: 18028111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diminished hippocalcin expression in Huntington's disease brain does not account for increased striatal neuron vulnerability as assessed in primary neurons.
    Rudinskiy N; Kaneko YA; Beesen AA; Gokce O; Régulier E; Déglon N; Luthi-Carter R
    J Neurochem; 2009 Oct; 111(2):460-72. PubMed ID: 19686238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional and cellular gene expression changes in human Huntington's disease brain.
    Hodges A; Strand AD; Aragaki AK; Kuhn A; Sengstag T; Hughes G; Elliston LA; Hartog C; Goldstein DR; Thu D; Hollingsworth ZR; Collin F; Synek B; Holmans PA; Young AB; Wexler NS; Delorenzi M; Kooperberg C; Augood SJ; Faull RL; Olson JM; Jones L; Luthi-Carter R
    Hum Mol Genet; 2006 Mar; 15(6):965-77. PubMed ID: 16467349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential modulation of dopamine D1-receptor binding and mRNA expression in the basal ganglia by the D1-receptor antagonist, SCH-23390.
    Yu J; Coirini H; Källström L; Wiesel FA; Johnson AE
    Synapse; 1998 Sep; 30(1):38-48. PubMed ID: 9704879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.